Kamaleddin H. M. E. Tehrani

1.0k citations

27 papers · 777 indexed · h-index 19

Co-authors: Nathaniel I. Martin Vida Mashayekhi Farzad Kobarfard Maryam Hashemi Mir‐Jamal Hosseini Maryam Hassan Matthijs J. van Haren Soroush Sardari
Topics: Antibiotic Resistance in Bacteria (12 papers)Synthesis and biological activity (6 papers)Antibiotics Pharmacokinetics and Efficacy (5 papers)
Cited by: Molecular Medicine Applied Microbiology and Biotechnology Pharmacology
Journals: Journal of Biological Chemistry Angewandte Chemie International Edition Chemical Communications
Partner nations: Netherlands Iran United States

In The Last Decade

Kamaleddin H. M. E. Tehrani

27 papers receiving 763 citations

Peers

Countries citing papers authored by Kamaleddin H. M. E. Tehrani

Since Specialization

Citations

This map shows the geographic impact of Kamaleddin H. M. E. Tehrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamaleddin H. M. E. Tehrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamaleddin H. M. E. Tehrani more than expected).

Fields of papers citing papers by Kamaleddin H. M. E. Tehrani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamaleddin H. M. E. Tehrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamaleddin H. M. E. Tehrani. The network helps show where Kamaleddin H. M. E. Tehrani may publish in the future.

Co-authorship network of co-authors of Kamaleddin H. M. E. Tehrani

This figure shows the co-authorship network connecting the top 25 collaborators of Kamaleddin H. M. E. Tehrani. A scholar is included among the top collaborators of Kamaleddin H. M. E. Tehrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamaleddin H. M. E. Tehrani. Kamaleddin H. M. E. Tehrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Darobactins Exhibiting Superior Antibiotic Activity by Cryo‐EM Structure Guided Biosynthetic Engineering** 2022 ·Angewandte Chemie International Edition ·(unknown),(unknown),(unknown),(unknown),Fabian Panter,Chantal D. Bader,(unknown),(unknown),Kamaleddin H. M. E. Tehrani,Paul G. Higgins,Harald Seifert,Thomas C. Marlovits,Jennifer Herrmann,Rolf Müller	32
2	Mechanistic Investigations of Metallo‐β‐lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition** 2021 ·ChemMedChem ·(unknown),Kamaleddin H. M. E. Tehrani,(unknown),Matthijs J. van Haren,Vida Mashayekhi,Nathaniel I. Martin	24
3	Aspergillomarasmine A inhibits metallo-β-lactamases by selectively sequestering Zn2+ 2021 ·Journal of Biological Chemistry ·David Sychantha,(unknown),Kamaleddin H. M. E. Tehrani,Nathaniel I. Martin,Gerard D. Wright	28
4	Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance 2020 ·Chemistry - A European Journal ·Matthijs J. van Haren,Kamaleddin H. M. E. Tehrani,(unknown),(unknown),(unknown),Vida Mashayekhi,Nathaniel I. Martin	19
5	Aminocarboxylic acids related to aspergillomarasmine A (AMA) and ethylenediamine-N,N′-disuccinic acid (EDDS) are strong zinc-binders and inhibitors of the metallo-beta-lactamase NDM-1 2020 ·Chemical Communications ·Kamaleddin H. M. E. Tehrani,Haigen Fu,(unknown),Vida Mashayekhi,(unknown),Matthijs J. van Haren,Gerrit J. Poelarends,Nathaniel I. Martin	18
6	Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem 2020 ·ACS Infectious Diseases ·Kamaleddin H. M. E. Tehrani,(unknown),(unknown),Vida Mashayekhi,Diego Pesce,Matthijs J. van Haren,Nathaniel I. Martin	22
7	Novel Carbapenemases FLC-1 and IMI-2 Encoded by an Enterobacter cloacae Complex Isolated from Food Products 2019 ·Antimicrobial Agents and Chemotherapy ·Michael S. M. Brouwer,Kamaleddin H. M. E. Tehrani,Michel Rapallini,Yvon Geurts,Arie Kant,Frank Harders,Vida Mashayekhi,Nathaniel I. Martin,Alex Bossers,Dik Mevius,Ben Wit,Kees Veldman	21
8	β-lactam/β-lactamase inhibitor combinations: an update 2018 ·MedChemComm ·Kamaleddin H. M. E. Tehrani,Nathaniel I. Martin	107
9	A New Tool to Reveal Bacterial Signaling Mechanisms in Antibiotic Treatment and Resistance 2018 ·Molecular & Cellular Proteomics ·Miao‐Hsia Lin,Clément M. Potel,Kamaleddin H. M. E. Tehrani,Albert J. R. Heck,Nathaniel I. Martin,Simone Lemeer	23
10	Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7 2017 ·ACS Infectious Diseases ·(unknown),(unknown),(unknown),(unknown),Zishuo Cheng,(unknown),Hao Yang,Mahesh Aitha,M. Rachel Mehaffey,Jennifer S. Brodbelt,Kamaleddin H. M. E. Tehrani,Nathaniel I. Martin,Robert A. Bonomo,Richard C. Page,David L. Tierney,Walter Fast,Gerard D. Wright,Michael W. Crowder	47
11	De novo identification of lipid II binding lipopeptides with antibacterial activity against vancomycin-resistant bacteria 2017 ·Chemical Science ·Peter ‘t Hart,Thomas M. Wood,Kamaleddin H. M. E. Tehrani,Roel M. van Harten,(unknown),Inmaculada Rentero Rebollo,Antoni P. A. Hendrickx,Rob J. L. Willems,Eefjan Breukink,Nathaniel I. Martin	14
12	Mitochondrial oxidative stress and dysfunction induced by isoniazid: study on isolated rat liver and brain mitochondria 2015 ·Drug and Chemical Toxicology ·(unknown),Mohammad Reza Eskandari,Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,(unknown),Parvaneh Naserzadeh,Mir‐Jamal Hosseini	60
13	Mechanistic approach for the toxic effects of perfluorooctanoic acid on isolated rat liver and brain mitochondria 2015 ·Human & Experimental Toxicology ·Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,Mahmoud Hashemzaei,Kaveh Tabrizian,Jafar Shahraki,Mir‐Jamal Hosseini	52
14	Synthesis and Antimycobacterial Activity of some Triazole Derivatives-New Route to Functionalized Triazolopyridazines. 2015 ·PubMed ·Kamaleddin H. M. E. Tehrani,Vida Mashayekhi,(unknown),(unknown),Soroush Sardari,Farzad Kobarfard	12
15	Synthesis, Antiplatelet Activity and Cytotoxicity Assessment of Indole-Based Hydrazone Derivatives. 2015 ·PubMed ·Kamaleddin H. M. E. Tehrani,(unknown),Vida Mashayekhi,Maryam Hashemi,Farzad Kobarfard,(unknown),(unknown)	15
16	Synthesis and antibacterial activity of Schiff bases of 5-substituted isatins 2015 ·Chinese Chemical Letters ·Kamaleddin H. M. E. Tehrani,Maryam Hashemi,Maryam Hassan,Farzad Kobarfard,(unknown)	77
17	Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones 2013 ·Archives of Pharmacal Research ·Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,(unknown),Soroush Sardari,Farzad Kobarfard	22
18	Synthesis of thioether derivatives of quinazoline-4-one-2-thione and evaluation of their antiplatelet aggregation activity 2013 ·Archives of Pharmacal Research ·(unknown),(unknown),Kamaleddin H. M. E. Tehrani,Vida Mashayekhi,Farzad Kobarfard	21
19	Synthesis of Novel Indole Hydrazone Derivatives and Evaluation of Their Antiplatelet Aggregation Activity 2012 ·Chemical and Pharmaceutical Bulletin ·Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,Salimeh Amidi,Farzad Kobarfard	40
20	One Pot Synthesis and Biological Activity Evaluation of Novel Schiff Bases Derived from 2-Hydrazinyl-1,3,4-thiadiazole 2012 ·Chemical and Pharmaceutical Bulletin ·Kamaleddin H. M. E. Tehrani,Soroush Sardari,Vida Mashayekhi,(unknown),(unknown),Farzad Kobarfard	26

About Kamaleddin H. M. E. Tehrani

Kamaleddin H. M. E. Tehrani is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology, having authored 27 papers that have together received 777 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Synthesis and biological activity (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Molecular Medicine (305 citations), Applied Microbiology and Biotechnology (61 citations) and Pharmacology (195 citations). Kamaleddin H. M. E. Tehrani has collaborated with scholars based in Netherlands, Iran and United States. Frequent co-authors include Nathaniel I. Martin, Vida Mashayekhi, Farzad Kobarfard, Maryam Hashemi, Mir‐Jamal Hosseini, Maryam Hassan, Matthijs J. van Haren, Soroush Sardari, Salimeh Amidi and Mahmoud Hashemzaei. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Chemical Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact